Late recurrence of Graves' disease

Area of Science:

• Endocrinology
• Internal Medicine
• Clinical Case Studies

Background:

• Graves' disease is an autoimmune disorder causing hyperthyroidism.
• Carbimazole is a common antithyroid medication used for Graves' disease treatment.
• Relapse of Graves' disease can occur after treatment, but late recurrences are uncommon.

Observation:

• A patient previously treated for Graves' disease with carbimazole presented with disease recurrence.
• The recurrence was diagnosed after a significant disease-free interval of 31 years.
• This represents a rare instance of very late-onset hypothyroidism after prolonged remission.

Findings:

• The patient experienced a recurrence of Graves' disease after 31 years of remission.
• This extended disease-free period challenges typical relapse timelines.
• The case underscores the importance of long-term patient monitoring.

Implications:

• This case suggests that patients treated for Graves' disease may require lifelong monitoring, even after decades of remission.
• Understanding the mechanisms behind late recurrences is crucial for refining treatment strategies.
• Further research into factors predicting late-onset hypothyroidism is warranted.